ASTA Draft Risk Profile Comments
ASTA issued a comment to the Food and Drug Administration (FDA) in March 2014 regarding the FDA's Draft Risk Profile on Pathogens and Filth in Spice.
03/03/2014 at 5:15 am
1
Related Resources
ASTA Comments on Poppy Seed Practices and Safety
On June 16, 2025, ASTA submitted comments in response to the U.S. Food and Drug Administration's (FDA) Request for Information (RFI) on industry practices on the growing, harvesting, processing, and distribution of poppy seeds. The comments outline the typical poppy seed supply chains, as well as the role of pre- and post-harvest processing steps (e.g., microbiological treatment, baking, etc.) in reducing opiate alkaloid levels in poppy seed-based products.
ASTA Comments on FDA's Post-Market Assessment of Chemicals in Food
In January 2025, ASTA submitted comments to the U.S. Food and Drug Administration (FDA) on its discussion paper on the development of an enhanced systematic process for the post-market assessment of chemicals in food. ASTA's comment note that environmental contaminants are unique and should be addressed using a separate or modified approach to that used for intentionally added chemicals. The comments also call for the development of additional guidance to assist industry with setting appropriate thresholds for contaminants.